AND-Gate Logic Förster Resonance Energy Transfer/Magnetic Resonance Tuning Nanoprobe for Programmable Antitumor Immunity Imaging

• Published in: Journal of the American Chemical Society 2024-11, Vol.146 (46), p.31873-31884
• Main Authors: Ma, Xianbin, Mao, Mingchuan, Liu, Zhenya, Liang, Chao, He, Jiaqi, Qu, Yun, Xu, Luzheng, Cheng, Ran, Zhuang, Wanru, Lei, Yao, Nie, Weidong, Yuan, Lan, Pang, Dai-Wen, Xie, Hai-Yan
• Format: Article
• Language: English
• ISSN: 0002-7863; 1520-5126; 1520-5126
• DOI: 10.1021/jacs.4c11072

Simultaneous detection of different biomarkers related to the spatiotemporally dynamic immune events is of particular importance for the accurate evaluation of antitumor immune effects. Here, we have developed an AND-gate logic dual resonance energy transfer nanoprobe (named DRET) for dynamic monitoring of programmed CD8 T cell activation and tumor cell apoptosis. Immunotherapy-induced granzyme B secretion from CD8 T cells and the subsequent caspase-3 release from apoptotic tumor cells individually activate one of the tiers of the "AND-gate" logic DRET. The resulting fluorescence recovery and magnetic resonance T1 enhancement can be used for precise immunomodulatory drug screening, early efficacy prediction, and immune stratification. Particularly, not only "Responders" can be distinguished from "Non-responders", but also "Acquired resistance" can be identified from "Maintain responders", providing a novel approach to put forward the accurate evaluation of antitumor immunity.